3-(4-(4-(2-Phenyl-1,3-dioxan-5-ylcarbonyl)piperazin-1-yl)-3-fluorophenyl)-5(R)-(isoxazol-3-yloxymethyl)oxazolidin-2-one → 3-(4-(4-(3-Hydroxy-2-hydroxymethylpropanoyl)piperazin-1-yl)-3-fluorophenyl)-5(R)-(isoxazol-3-yloxymethyl)oxazolidin-2-one
Reaction equation
C1(C2[O:12][CH2:11][CH:10]([C:13]([N:15]3[CH2:20][CH2:19][N:18]([C:21]4[CH:26]=[CH:25][C:24]([N:27]5[CH2:31][C@H:30]([CH2:32][O:33][C:34]6[CH:38]=[CH:37][O:36][N:35]=6)[O:29][C:28]5=[O:39])=[CH:23][C:22]=4[F:40])[CH2:17][CH2:16]3)=[O:14])[CH2:9][O:8]2)C=CC=CC=1>C(O)(=O)C.O>[OH:8][CH2:9][CH:10]([CH2:11][OH:12])[C:13]([N:15]1[CH2:20][CH2:19][N:18]([C:21]2[CH:26]=[CH:25][C:24]([N:27]3[CH2:31][C@H:30]([CH2:32][O:33][C:34]4[CH:38]=[CH:37][O:36][N:35]=4)[O:29][C:28]3=[O:39])=[CH:23][C:22]=2[F:40])[CH2:17][CH2:16]1)=[O:14]Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
3-(4-(4-(2-Phenyl-1,3-dioxan-5-ylcarbonyl)piperazin-1-yl)-3-fluorophenyl)-5(R)-(isoxazol-3-yloxymethyl)oxazolidin-2-one (450 mg, 0.82 mmol) was dissolved in a mixture of acetic acid and water (4:1, 10 ml) and stirred at ambient temperature for 18 hours. After evaporation to dryness, the residue was azeotroped with toluene (15 ml), and the residual gum purified by chromatography on a 20 g silica Mega Bond Elut® column, eluting with a gradient increasing in polarity from 5 to 10% MeOH in dichloromethane. Relevant fractions were combined and evaporated to give the desired product (237 mg).
Workup
- customAfter evaporation to dryness
- customthe residue was azeotroped with toluene (15 ml)
- customthe residual gum purified by chromatography on a 20 g silica Mega Bond Elut® column
- washeluting with a gradient
- temperatureincreasing in polarity from 5 to 10% MeOH in dichloromethane
- customevaporated
Sources & evidence
- ORD record
- ord-f9fe235db3d44b55ba312612fd5889fc
- Source dataset
- uspto-grants-2003_09
- Patent number
- US06617339B1
Reaction notes
Loading…